TABLE 2.
Proposed deglucuronidation-based antiviral mechanism.
Stage A—Infection by any of several virus species induces inflammation |
↓ |
Stage B—Flavonoid aglycones are glucuronidated prior to arrival in the bloodstream |
↓ |
Stage C—Neutrophils and macrophages are attracted to site(s) of inflammation |
↓ |
Stage D—β-glucuronidase is expressed by neutrophils and macrophages |
↓ |
Stage E—Serum flavonoid glucuronides are deglucuronidated (“deconjugated”) by β-glucuronidase at site of inflammation |
↓ |
Stage F—Flavonoid aglycones diffuse through cell membrane |
↓ |
Stage G—Flavonoid aglycones cause non-selective (and non-specific) inhibition within the cell—interfering with both ordinary cellular processes and the etiological source of inflammation (such as viral replication) |